Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studiesNele Boeckx, Marc Peeters, Guy Van Camp et al.|Annals of Oncology|2017Cited by 219
The Prime Study: Survival Outcomes in Patients with KRAS/NRAS Wild-Type Metastatic Colorectal Cancer and Non-Liver-Limited DiseaseJean‐Yves Douillard, R. Sidhu, Jan-Henrik Terwey et al.|Annals of Oncology|2014Cited by 0